CARsgen Claims First Clinical Win For CLDN 18.2 CAR-T In G/GEJ Adenocarcinoma

 
• By Dexter Jie Yan
  
3D illustration of T cells attacking a cancer cell (CAR-T cell therapy) - Illustration
Satri-cel is the world's first CAR-T cell therapy candidate that has reported positive results in a pivotal clinical trial for solid tumors. • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Cell Therapies

More from Focus On Asia